Home » Preclinical development of embryonic ectoderm development (EED) inhibitor APG-5918/EEDi-5273 for cancer therapy
2022
Zhu S, Fang DD, Li Q, Yang D, Gu S, Wang S, Yang D, Zhai Y. Preclinical development of embryonic ectoderm development (EED) inhibitor APG-5918/EEDi-5273 for cancer therapy. Cancer Res. [Poster presented at: AACR Annual Meeting 2022; April 8-13, 2022; New Orleans, LA]. vol. 82 no. (suppl 12):, pp. 3939-3939, doi: 10.1158/1538-7445.AM2022-3939